JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2016/22737.8823
Year : 2016 | Month : Nov | Volume : 10 | Issue : 11 Full Version Page : OC05 - OC08

Physician Related Delays in the Diagnosis of Lung Cancer in India

Krishnappriya Ramachandran1, Balamugesh Thankagunam2, Reka Karuppusami3, DJ Christopher4

1 Assistant Professor, Department of Respiratory Medicine, Meenakshi Medical College Hospital and Research Institute, Enathur, Kanchipuram, Tamil Nadu, India.
2 Professor, Department of Pulmonary Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
3 Senior Demonstrator, Department of Biostatistics, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
4 Professor and Head, Department of Pulmonary Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Krishnappriya Ramachandran, Assistant Professor, Department of Respiratory Medicine, Meenakshi Medical College Hospital and Research Institute, Enathur, Kanchipuram, Tamil Nadu, India.
E-mail: drkpriya78@gmail.com
Abstract

Introduction

Lung cancer is associated with a poor prognosis, if detected late in the disease course. Delay in seeking health care, wrong diagnosis and delay in specialist referral can contribute to delay in diagnosis.

Aim

This study was done to assess physician related delays in the diagnosis of lung cancer and the treatments given before presenting to our center.

Materials and Methods

A total of 96 condivutive patients diagnosed with lung cancer were enrolled in this study. Details of previous physician consultations, their specialization, diagnoses made and treatments given were obtained from records available with the patients.

Results

Patients, on an average consulted two physicians before presenting to our center. Less than half of the physicians (45%) suspected lung cancer during their evaluation. Around 18% of physicians made an incorrect diagnosis of tuberculosis, out of whom, 88.6% had prescribed anti-tuberculous therapy. Only 27% of physicians referred the patients to higher medical centres for evaluation. Pulmonology Specialists (PS) were the most likely to diagnose lung cancer (p<0.0001). General Medicine Specialists (GMS) were the most likely to misdiagnose cancer as tuberculosis, followed by General Practioners (GP) when compared to PS (p-value =0.0422).

Conclusion

Our study demonstrates that, many physicians have a low index of suspicion to diagnose lung malignancy and most commonly misdiagnose it as tuberculosis. It is likely that most patients failed to seek the services of PS directly or through referral either due to a shortage of PS or due to other reasons.

Keywords

Introduction

In India, lung cancer is the most common cancer as well as the most common tumor causing death in men. Lung cancer accounts for around 7% of all newly diagnosed cancer cases and 9.3% of all cancer related mortality in both sexes [1]. Survival in lung cancer depends on the stage of the disease at diagnosis [2]. Timely diagnosis remains critical to improve curability and prompt specialist referral is the most important pre-requisite for an early diagnosis [3].

Previous studies have shown that, most patients with lung cancer are diagnosed late in the disease course [4,5]. This could be due to a multitude of factors, such as patient related delay and lack of awareness leading to delay in seeking healthcare, inadequate or inaccessible health care facilities and physician related delays, like incorrect diagnosis and delayed referral to appropriate specialists. Data is lacking on physician related delays such as incorrect diagnosis and delayed referral in India.

We therefore, did this study to analyze the time to diagnose and assess physician related delays in diagnosis and the management plan/treatment given before presenting to our center.

Materials and Methods

The study was conducted prospectively in the Department of Pulmonary Medicine at a Tertiary Care Hospital in Southern India between November 2006 and May 2007. All patients diagnosed with lung cancer in the department were included in the study after obtaining informed consent. Information was collected with regards to the clinical symptoms, their duration and other relevant information. Details of previous physician consultations, their specialization/qualification, their diagnoses and the details of treatment received were obtained from records available with the patients. Non-allopathic practitioners were excluded from the study. Physical examination findings, histopathology, radiology reports and reports of other relevant investigations carried out at our center were collected.

The physicians who attended to the patient were classified according to specialization/qualification as:

1. General Practitioner (GP): Basic medical degree (MBBS) or degree in surgical or unrelated medical specialties.

2. General Medicine Specialist (GMS): MD (General internal medicine) and those with medical super specialties other than pulmonary medicine.

3. Pulmonology Specialist (PS): MD (Respiratory medicine or equivalent) who have had a 3 year specialty training or DM (Pulmonary Medicine or equivalent) who have had a 3 year specialty training, after 3 years of Internal Medicine training.

4. Respiratory Diploma (RD): A 2 year diploma in Tuberculosis and Chest Diseases (DTCD) or equivalent.

Statistical Analysis

The results were expressed in terms of frequencies and percentages for categorical variables. For continuous data, the mean and standard deviation was calculated. Chi-square test was used to assess the association between the physicians’ specialization/qualification and their diagnostic accuracy. Statistical analysis was carried out using Statistical Analysis System (SAS) version 9.4.

Results

A total of 96 patients were included in the study over the seven month study period and they had records of 196 physician consultations. Mean duration of symptoms at the time of consultation at our center was 5.8 months and 42 (43.8%) of the patients had consulted one, 28 (29.1%) consulted two, 13 (13.5%) consulted three, 6 (6.3%) consulted four physicians and 7 (7.3%) had consulted five physicians before coming to us.

The details of the physicians consulted are shown in [Table/Fig-1].

Qualification of physicians consulted.

Qualificationn(%)*
General Medicine Specialist (GMS)95(48.5)
General Practitioner (GP)62(31.6)
Pulmonology Specialist (PS)29(14.8)
Respiratory Diploma (RD)10(5.1)
Total196

*n (%) =number (percentage) of given characteristics


Diagnoses made by the physicians: A total of 22 (11.2%) physicians made a histological diagnosis of lung cancer and four had commenced chemotherapy. Although these patients were histologically confirmed cases, they consulted our center for a second opinion.

Overall, less than half of the physicians 88 (45%) suspected lung cancer. When looked at with respect to their specialization and qualification, 14 (22.6%) of the GPs, 4 (40%) of the RDs, 43 (45%) of the GMS and 27 (93.1%) of the PS had suspected lung cancer. Thus, PS appeared to be the most likely to suspect lung cancer compared to GMS and GPs (p<0.0001) [Table/Fig-2].

Association between qualification of physicians and diagnosis of lung cancer made.

Qualification ofPhysiciansDiagnosis of lungcancer maden(%)Diagnosis of lungcancer not maden (%)p-value*
Pulmonology Specialist27(93.1)2 (6.9)<0.0001
General Medicine Specialist43(45.3)52(54.7)
General Practitioner14(22.6)48(77.4)
Respiratory Diploma4(40)6(60)

*p value using Chi Square test.

n (%) =number (percentage) of given characteristics


The most common misdiagnosis appeared to be smear negative pulmonary tuberculosis (18%), followed by Lower Respiratory Tract Infection (LRTI) (5.6%) and Chronic Obstructive Pulmonary Disease (COPD) (5.1%) [Table/Fig-3]. Of the 35 physicians (18%), who made a diagnosis of tuberculosis, 31 (88.6%) commenced Anti-Tubercular Therapy (ATT); (One physician made a correct diagnosis of lung cancer but decided to start the patient on concurrent ATT. Hence, the total number of physicians who started ATT was 32 as shown in the [Table/Fig-4].

Diagnoses by physicians.

Diagnosis maden(%)*
Lung cancer88(44.9)
Tuberculosis35(17.8)
Lower Respiratory Tract infection11(5.6)
Chronic Obstructive Pulmonary Disease10(5.1)
Pneumonia8(4.1)
Vocal cord Palsy7(3.6)
Cough of unknown etiology7(3.6)
Others30(15.3)
Total196

*n (%) =number (percentage) of given characteristics


Action taken by physicians– referral/treatments/investigations.

Action takenn (%)*
Referral54(27.6)
Antituberculous treatment (ATT)32(16.4)
Antibiotic treatment23(11.7)
Ordered investigations21(10.7)
Cough syrup14(7.1)
Bronchodilators8(4.1)
Chemotherapy4(2)
Others18(9.2)
Total196

*n (%) =number (percentage) of given characteristics


Misdiagnosis of tuberculosis was made by 22 (23.1%) GMS, 12 (19.3%) GPs and 01 (3.4%) PS, suggesting that GMS were the most likely to misdiagnose cancer as tuberculosis closely followed by GPs while PS were the least likely (p-value = 0.0422).

Diagnosis made by the physicians first consulted: A total of 38 (41%) out of 96 physicians first consulted suspected lung cancer at the patient’s first visit; 23 (60.5%) of them made referrals to higher centers for further evaluation, 10 of them ordered further investigations to confirm the diagnosis (four obtained biopsy confirmation), 3 prescribed antibiotics empirically, one prescribed ATT and one prescribed only bronchodilators, despite suspicion of cancer. Misdiagnosis as tuberculosis was made by 20 (21.7%) and 38 made other misdiagnoses or referrals.

Referrals and treatment details: In all, 54 (27.6%) of the physicians referred the patients to higher medical centers; 33%, 20% and 26% of these were at first, second and third physician consultation respectively and 39 (72%) out of these physicians had suspected lung cancer before referral.

The treatment details provided by the physicians are tabulated in [Table/Fig-4]. The most frequently offered treatment was ATT, followed by antibiotics. A total of 21 (10.7%) ordered further investigations and had not commenced any treatment until the patients came to our center.

Disease stage at diagnosis: After complete evaluation, 40 (41.7%) patients had Stage IV and 31(33.3%) had Stage IIIB disease at the time of diagnosis. Only 11 (11.5%) patients were considered to have operable disease according to 1999 TNM staging [6] used in this study [Table/Fig-5].

Details of staging and operability of lung cancer.

OperabilityNon small cell carcinoman=91Small cell carcinoman=5
Operable11(IA-1, IB-4, IIA-1, IIB-4, IIIA-1)Limited = 1
Inoperable78 (IIIA-7, IIIB-31, IV-40)Extensive = 4
Staging could not be ascertained2

Discussion

Most of the patients had consulted an average of two physicians before coming to us. We looked at data from various Indian studies and this has been shown in [Table/Fig-6] [4,5,79]. Duration of time delay to diagnosis was shorter in most studies except Dubey et al., [5] which was similar to the delay in our study (around 6 months). Staging at diagnosis in other studies was similar to our study (74%- Stage IIIB, IV) except in Chandra et al., (90%) [9].

Comparison of the present study data with other Indian studies.

StudyNo of ptsSymptom todiagnosis delayNo. of pts misdiagnosedas TBn*and/or%†Period of studyStage of disease atdiagnosisPlace ofstudyType of study
Present study965.8 months29.2%7 months (Nov 2006 -May 07)40 (41.7%)stage IV31 (33.3%)stage IIIBVellore,Tamil NaduProspective
Yogeesha et al., [7]613-4 monthsTB - 3(5%), pneumonia-32(52%)6 months (Aug 2013-Jan 2014)Not specifiedKarnatakaRetrospective
Rawat et al., [4]2034-6 monthsMentioned as majority of cases, numbers not specifiedJan 1998-Aug 200573.29% stage IIIB, IVUttarakhandRetrospective
Rahul et al., [8]1703 months43%2 yearsNot specifiedJammuProspective
Dubey et al., [5]475.7 months11 (23.4%)1 year (2012-2013)29 (65.8%), stage IIIB, IVMadhya PradeshProspective
Chandra et al., [9]1654.8 months28 (17%)Jan 2002 – Dec 200890.2% Stage IIIB, IVNew DelhiRetrospective

*n =number of given characteristics†%=percentage


In a study done in Turkey [10], which included 101 lung cancer patients, 18.8% patients were examined by one physician, 42.6% by two, 26.7% by three, and 11.9% by four or more as compared to 43.8%, 28.1%, 13.5% and 7.3% patients respectively in our study. A large number of our patients consulted GMS and GPs, despite significant respiratory symptomatology, suggesting that these were more readily available options compared to PS. Only 15% of the patients consulted a PS, although they could be reached directly without GP referral in India.

Improvement in detection rates can be achieved by health edu-cation for the public as well as sensitizing doctors [3]. Unfortunately, less than half of the physicians (n=88, 44.9%) suspected lung cancer in our study while 35 physicians (18%), made an incorrect diagnosis of tuberculosis. Misdiagnosis accounted for significant delay in referral for confirmation of diagnosis and the most common misdiagnosis was tuberculosis. In two Indian studies, 17% and 22% of patients respectively with bronchogenic carcinoma were wrongly diagnosed initially as pulmonary tuberculosis and were prescribed ATT by the physicians [9,11]. In our study, this number was more; 29.2% patients were misdiagnosed as having tuberculosis and 27.1% were treated with ATT. The general tendency among physicians in India is to empirically diagnose tuberculosis much more commonly than cancer due to the high endemicity of tuberculosis and a shortage of diagnostic facilities for confirming the diagnosis of lung cancer using tools such as Computed Tomography (CT) guided lung biopsy and bronchoscopy [9]. Moreover, the Tuberculosis Control Programme advises physicians to commence empirical ATT for patients with lung shadows that don’t resolve with antibiotic treatment. It is a widely held view that lung cancer diagnosis is a death sentence, with no curative treatment options. Many Indian physicians have a pragmatic approach of empirically treating for a curable disease and thus, antibiotic treatment, especially ATT is commonly used.

In a Brazilian study [12], only 24 (8%) patients were referred to a specialist following first contact with a physician while around 64% were referred after the third physician consultation. Pneumonia, chronic bronchitis and tuberculosis were diagnosed in 20%, 9% and 8% respectively. In our study, 32% of doctors referred the patients to higher centers at first consultation. In another study [13] done on 3855 patients with lung cancer, a specialist respiratory physician was involved in the initial management of 2,901 (75.3%) patients and the survival of these patients after 1 year of diagnosis was significantly higher (24.4 versus 11.1%).

In a Swedish study [14] done in 134 lung cancer patients, the median delay from the onset of the first symptom until, contact with the family doctor was 21 days, the median time to specialist referral was 33 days and the median time taken in establishing the diagnosis was nine days following the specialist visit. Overall, the median time from first symptom(s) until treatment or the decision not to treat was around six months. The delay was mostly due to the inadequacy of medical services, delay in referrals and in the performance of subsidiary tests. In our study, the average duration from the onset of symptoms to the consultation at our center was close to six months.

Early detection of lung cancer leads to better operability and improved outcomes [15,16], which in turn is dependent upon patient related delays and diagnostic delays [17]. The British Thoracic Society recommends immediate referral of patients with discernible evidence of lung cancer to a respiratory specialist [18]. Such a recommendation, we feel would be appropriate for India in the light of our study. In a retrospective study [17], lung specialist treatment delays did not correlate with poor prognosis in patients with late stage disease. However, this might be crucial in patients with early lung cancer where early detection and prompt treatment can lead to excellent outcomes.

Limitation

One of the limitations of the study was that we obtained information about previous physician consults from records that the patients had and thus, we could have missed a few. We also did not obtain details of physicians from alternate medical streams, who could also have been consulted. Thus, the number of physicians consulted before presentation to us could be an under estimate.

Conclusion

The study makes one wonder if there is an inadequacy of pulmonology specialists. Awareness has to be created among GPs and GMS about the early symptoms and signs of lung cancer and the need for prompt referral to a PS that would in turn assist in early histological diagnosis and a better chance of operability and cure.

*n (%) =number (percentage) of given characteristics*p value using Chi Square test.n (%) =number (percentage) of given characteristics*n (%) =number (percentage) of given characteristics*n (%) =number (percentage) of given characteristics*n =number of given characteristics†%=percentage

References

[1]Malik PS, Raina V, Lung cancer: Prevalent trends and emerging concepts(Editorial) Ind J Med Res 2015 141(1):5-7.  [Google Scholar]

[2]Vansteenkiste J, Buccheri G, Carney DN, Prognostic factors in nonsmall cell lung cancer Eur Resp J 2002 12:156-171.  [Google Scholar]

[3]Buccheri G, Ferrigno D, Lung cancer: Clinical presentation and specialist referral time ERS 2004 24:898-904.  [Google Scholar]

[4]Rawat J, Sindhwani G, Gaur D, Dua R, Saini S, Clinico-pathological profile of lung cancer in Uttarakhand Lung India 2009 26(3):1-3.  [Google Scholar]

[5]Dubey N, Julka A, Varudkar HG, Agrawat JC, Bhandari D, Mukati S, A clinico-pathological profile of primary lung cancer patients presenting in a rural medical college of Central India Panacea J Med Sci 2015 5(3):124-29.  [Google Scholar]

[6]Lababede O, Meziane MA, Rice TW, TNM Staging of lung cancer: A quick reference chart Chest 1999 115:233-35.  [Google Scholar]

[7]Yogeesha KS, Vijayamahantesh NN, Raghavendra BS, Nishitha S, Arunachalam R, Navin AP, Clinical presentation of lung cancer in adults: A retrospective study of 61 patients from a tertiary care center in South India Int J Appl Basic Med Res 2014 4(1):195-97.  [Google Scholar]

[8]Gupta R, Chowdhary I, Singh P, Clinical, radiological and histological profile of Primary Lung Carcinomas JK Science 2015 17(3):146-151.  [Google Scholar]

[9]Chandra S, Mohan A, Guleria R, Singh V, Yadav P, Delays during the diagnostic evaluation and treatment of lung cancer Asian Pac J Cancer Prev 2009 10:453-56.  [Google Scholar]

[10]Sulu E, Tasolar O, Berk TH, Yagci TL, Karakurt Z, Yilmaz A, Delays in the diagnosis and treatment of non-small-cell lung cancer Tumori 2011 97(6):693-97.  [Google Scholar]

[11]Prasad R, James P, Kesarwani V, Gupta R, Pant MC, Chaturvedi A, Clinicopathological study of bronchogenic carcinoma Respirology 2004 9(4):557-60.  [Google Scholar]

[12]Pereira JR, Ikari FK, Minamoto H, Cassioli JC, Delay factors in the diagnosis of lung cancer: a public health problem Rev Paul Med 1991 109(3):109-12.  [Google Scholar]

[13]Fergusson RJ, Thomson CS, Brewster DH, Brownz PH, Milroy R, Lung cancer: The importance of seeing a respiratory physician Eurespir J 2003 21:606-10.  [Google Scholar]

[14]Koyi H, Hillerdal G, Branden E, Patient’s and doctors’ delays in the diagnosis of chest tumours Lung Cancer 2002 35:53-57.  [Google Scholar]

[15]Henschke CI, McCauley DI, Yankelevitz D, Early lung cancer action project: overall design and findings from baseline screening Lancet 1999 354:99-105.  [Google Scholar]

[16]Salomaa ER, Liippo K, Taylor P, Palmgren J, Haapakoski J, Virtamo J, Prognosis of patients with lung cancer found in a single chest x-ray screening Chest 1998 114:1514-18.  [Google Scholar]

[17]Salomaa ER, Sallinen S, Hiekkanen H, Liippo K, Delays in the diagnosis and treatment of lung cancer Chest 2005 128:2282-88.  [Google Scholar]

[18]BTS recommendations to respiratory physicians for organising the care of patients with lung cancer: The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee Thorax 1998 53(suppl):S1-S8.  [Google Scholar]